Philip Morris (PM) thrives with smoke-free innovations like IQOS and Zyn, driving $15B in revenue and gaining investor ...

British American Tobacco (BTI) remains a Hold for long-term investors amid declining revenues, rising costs and limited ...

Discover Veeco Instruments' Q1 2025 insights: strong semiconductor growth, Intel awards, and tariff challenges.

Total prescriptions and net product sales for Fanapt increased by 14% year-over-year, with new patient starts growing threefold. Vanda has expanded its psychiatry sales force to approximately 300 ...

QuidelOrtho's Q1 2025 earnings highlight strong growth in labs and flu-related sales, cost savings boosting margins, and confidence in hitting ...

Discover B&G Foods’ Q1 2025 earnings insights, challenges, and revised guidance. Explore strategic shifts, cost-saving plans, and key market trends.

IonQ’s Q1 2025 highlights growth in quantum computing with strategic acquisitions & a $22M system sale. Learn about revenue forecasts & scaling challenges.

Crude futures fell as concerns about rising OPEC+ production that had dragged down oil earlier this week outweighed positive signs of U.S.-China trade talks and a draw in U.S. crude stocks.

Challenges in maintaining high growth rates as the company expands its product portfolio.

Materialise's Q1 results beat low expectations, driven by its strong Medical segment. Discover why its growth potential ...

Discover why SPDR® Gold Shares ETF surged 18% in 3 months. Click for how GLD was driven higher by speculative buying, and why ...

Rigel Pharmaceuticals, Inc.'s 68% YoY revenue growth signals durable stock potential. Click for my RIGL earnings update and a ...